Not available
Quote | UroGen Pharma Ltd. (NASDAQ:URGN)
Last: | $15.01 |
---|---|
Change Percent: | -0.26% |
Open: | $15.18 |
Close: | $15.01 |
High: | $15.86 |
Low: | $14.89 |
Volume: | 366,060 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | UroGen Pharma Ltd. (NASDAQ:URGN)
2024-06-25 07:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 09:00:01 ET Read the full article on Seeking Alpha For further details see: UroGen Pharma stock slumps after pricing stock and warrants offering
Message Board Posts | UroGen Pharma Ltd. (NASDAQ:URGN)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
2024-06-25 07:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the pricing of an underwritten public offering of 5,000,000 ordinary shares at a price to the public of $17.50 per ord...
PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has commenced an underwritten public offering, subject to m...